$2.22 +0.5% vs prev close
HCAT Stock Price vs. AI Score Data gathered: January 27
3M 33.5%

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.


Health Catalyst
Price $2.22
Target Price Sign up
Volume 674,500
Market Cap $159M
Year Range $2.03 - $4.16
Dividend Yield 0%
Analyst Rating 75% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2576M39M38M-22M-3.9M0.060
Q2 '2581M42M38M-41M-22M-0.590
Q1 '2579M43M36M-24M-3.9M0.010
Q4 '2480M45M35M-21M-2.5M0.040
Q3 '2476M42M34M-15M-6.7M0.070

Insider Transactions View All

Landry Benjamin filed to sell 100,000 shares at $2.6.
December 9 '25
Larson-Green Julie filed to sell 73,573 shares at $2.7.
December 9 '25
Landry Benjamin filed to sell 141,812 shares at $3.4.
September 9 '25
Landry Benjamin filed to sell 151,125 shares at $3.9.
June 9 '25
LeSueur Daniel filed to sell 205,832 shares at $4.1.
May 7 '25

FAQ - Health Catalyst

The Market Cap of Health Catalyst is $159M.

Currently, the price of one share of Health Catalyst stock is $2.22.

The HCAT stock price chart above provides a comprehensive visual representation of Health Catalyst's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Health Catalyst shares. Our platform offers an up-to-date HCAT stock price chart, along with technical data analysis and alternative data insights.

As of our latest update, Health Catalyst (HCAT) does not offer dividends to its shareholders. Investors interested in Health Catalyst should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

Some of the similar stocks of Health Catalyst are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.